As oil prices fall, mergers and acquisitions (M&A) in the industry are likely to increase, according to observers. M&A allows for cost cuts and access to new assets, particularly for large oil companies. The first half of 2015 is expected to be slow for oil company M&A as valuations remain uncertain. Nonetheless, two deals that […]
The US Patent and Trademark Office (USPTO) issued new guidance this month on nature-based products. The new document is a revision of a guidance released in March stating that to be eligible for patents, such inventions must be “significantly different” and show structural differences from natural products (see IBO 7/15/14). Feedback from stakeholders claiming that […]
According to the “2014 EU Industrial R&D Investment Scoreboard,” the world’s top 2,500 companies for R&D investment spent €538.5 billion ($718.0 billion) on R&D in fiscal 2013, an increase of 4.9%. Net sales growth for these firms was 2.7%, and their capital spending increased 2.5%. Scoreboard companies each invested more than €15.5 million ($20.7 million) […]
Goettingen, Germany 12/19/14—Lab- and process-technology company Sartorius has agreed to sell its Industrial Technologies Division (Intec) to Japanese Minebea and the Development Bank of Japan. The sales price will be determined by Intec’s operating profit this year, but the parties have agreed on a 7.5 multiple of Intec’s 2014 operating EBITDA. “By selling our Intec […]
BioInformatics LLC has announced the 2014 Life Science Industry Awards. BioInformatics is a research and advisory firm for the life science industry. BioInformatics acquired SDi in September. The Life Science Industry Awards were nominated and voted on by nearly 6,000 scientists through electronic surveys conducted in September and October. The Awards covered more than 25 […]
With oil prices at a five-year low, down 20% since July, many oil companies are reducing costs. For example, ConocoPhillips will decrease by 20% its 2015 investment spending, and BP plans cuts to jobs over the next several months. However, ConocoPhillips expects its gas and oil production to increase by over 3% next year due […]
The value of the late-stage pipeline of a cohort of 12 major research-based life science companies has risen for the first time since 2010, growing 5.5% to $966 billion in 2014, versus 5.1% in 2013. Although the number of assets has fallen year over year from 194 to 181, the sales potential of the assets […]
In November, the US EPA proposed updates to the National Ambient Air Quality Standards for ground-level ozone. Both the primary (public health) and secondary (public welfare: protecting trees, plants and ecosystems) standards for the average level over any eight-hour period would be 65–70 ppb. Both are currently 75 ppb. Current and proposed federal rules, such […]
The global market for pharmaceuticals is expected to rise from $989 billion last year to $1,280–$1,310 billion by 2018, including the impacts of exchange-rate variability. Growth between 2014 and 2018 is expected to peak at 7% in 2014 due to the US. The combined annual growth rate (CAGR) for the US market from 2014 to […]
Of the $22.5 billion the NIH spent to support research In 2013, more than $5.7 billion was for indirect costs. Universities, nonprofits and hospitals received $3.9 billion, $611 million and $550 million, respectively, of this amount. Indirect costs are not linked to any specific project and are often for administrative and facilities expenses. The costs […]
Pay Invoice
Latest Blogs
-
Lab Instrument Sales in China Collapse
March 29, 2024 1:15 pm
-
Pittcon 2024 Comes to San Diego
February 14, 2024 1:10 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
